Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax sees weak Covid vaccine sales
Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
with which it signed a licensing deal earlier this year to sell its
COVID
vaccine
from 2025 in several markets, including the U.S. and
Europe
. The company is banking on revenue from its Sanofi deal and vaccines in development, including an experimental ...
FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine
The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.
Novavax sees weak Covid vaccine sales, convinced Sanofi can do better
Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals and a pipeline of new vaccines it's now evaluating for R&D.
Catholic News Agency
17h
Catholic woman awarded $12.7 million in religious discrimination lawsuit over COVID vaccine
In her religious excemption request, Lisa Domski wrote that taking the vaccine “would be a terrible sin and distance my ...
Imperial College London
2d
Pandemic preparedness cannot rely on vaccine development alone
Vaccine experts drew attention to disruption factors around vaccine development and key action plans for future pandemic ...
verywellhealth
6d
COVID Variant XEC Could Become Dominant Soon: How You Can Protect Yourself
The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...
7d
British doctor jailed for trying to kill mother's partner with fake Covid-19 jab
LONDON - A British doctor was on Wednesday jailed for more than 31 years for an audacious but unsuccessful plot to kill his ...
Hosted on MSN
1d
Novavax’s stock slides 7% as guidance cut offsets narrower-than-expected third-quarter loss
Novavax’s
COVID
-19
vaccine
won FDA approval in October 2023 ... partner Sanofi Sanofi will now lead the commercialization ...
1d
Morrison government’s $2 billion vaccine deal blasted
Australia’s audit office will probe the Morrison government’s $2 billion deal with US pharmaceutical giant Moderna to set up ...
6d
on MSN
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Moderna said its newest Covid vaccine saw benefits after winning approval in the U.S. three weeks earlier than the last ...
News Medical
17h
Inequities in COVID-19 vaccination coverage for older adults highlighted in global study
COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...
7d
Vaccine doses allocated for 9 African countries hardest hit by mpox
An initial 899,000 vaccine doses have been allocated for 9 countries across Africa that have been hit hard by the current ...
6d
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...
CTV News
4d
COVID-19 vaccine supply gaps expected to ease in Sask.
Saskatchewan is expecting a new shipment of updated COVID-19 vaccines next week, after a supply hiccup meant some couldn’t ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback